CordVida, established in 2003, is a pioneering company in the realm of Biotechnology and Health Care, headquartered in Brazil. They have carved a niche by focusing on the processing and storage of stem cell samples collected from umbilical cords. Their state-of-the-art laboratory is dedicated to ensuring the longevity and quality of preserved stem cells, serving thousands of clients across Brazil.
Renowned for innovation, CordVida has been recognized as one of the Top 10 stem cell banks worldwide by BioInformant, making them the sole representative of Latin America on this prestigious list. Their central mission underscores a commitment to enhancing the quality of life for families, reflecting in their reputation as a leading private entity facilitating familial health treatments.
While their growth has been significant, details on their last investment activities are unavailable, presenting potential opportunities for venture capitalists to explore partnerships with this influential biotechnology firm.